Research graph
References from Real-world treatment patterns and outcomes of brentuximab vedotin–based therapy in CD30-positive lymphomas in China: the prospective BRAVE study. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1056/nejmoa1708984
10.1056/nejmoa1708984 · 2018 · External reference
10.1016/s0140-6736(18)32984-2
10.1016/s0140-6736(18)32984-2 · 2019 · External reference
10.1200/jco-24-02242
10.1200/jco-24-02242 · 2025 · External reference
10.1016/j.annonc.2025.01.023
10.1016/j.annonc.2025.01.023 · 2025 · External reference
Unresolved reference
External reference
10.21147/j.issn.1000-9604.2021.03.01
10.21147/j.issn.1000-9604.2021.03.01 · 2021 · External reference
10.1007/s12672-025-02980-8
10.1007/s12672-025-02980-8 · 2025 · External reference
Unresolved reference
2025 · External reference
10.1007/s00277-025-06507-7
10.1007/s00277-025-06507-7 · 2025 · External reference
10.1038/s41409-025-02557-7
10.1038/s41409-025-02557-7 · 2025 · External reference
10.3389/fonc.2024.1494384
10.3389/fonc.2024.1494384 · 2024 · External reference
10.1097/hs9.0000000000000052
10.1097/hs9.0000000000000052 · 2018 · External reference
10.1038/s41408-019-0223-7
10.1038/s41408-019-0223-7 · 2019 · External reference
